AFFINITY-PURIFIED ESCHERICHIA-COLI J5 LIPOPOLYSACCHARIDE-SPECIFIC IGG PROTECTS NEUTROPENIC RATS AGAINST GRAM-NEGATIVE BACTERIAL SEPSIS

被引:35
作者
BHATTACHARJEE, AK [1 ]
OPAL, SM [1 ]
PALARDY, JE [1 ]
DRABICK, JJ [1 ]
COLLINS, H [1 ]
TAYLOR, R [1 ]
COTTON, A [1 ]
CROSS, AS [1 ]
机构
[1] BROWN UNIV,SCH MED,INFECT DIS SECT,PROVIDENCE,RI 02912
关键词
D O I
10.1093/infdis/170.3.622
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Antibodies were raised in rabbits by immunization with the heat-killed J5 mutant of Escherichia coli O111 (Re chemotype). Serum antibodies were separated into purified IgG and IgM by sequential affinity chromatography on protein G-Sepharose and anti-rabbit IgG-Sepharose columns. J5 lipopolysaccharide (LPS)-specific IgG was prepared by affinity chromatography of purified Ige on a J5 LPS-EAH Sepharose 4B affinity column. Purified IgM, IgG, and J5 LPS-specific IgG protected neutropenic rats against lethal challenge with Pseudomonas aeruginosa 12:4:4 (Fisher Devlin immunotype 6). Nine of 16 rats treated with the IgM fraction were protected (P < .001). Thirteen of 20 rats treated with the purified IgG and 6 of 8 treated with J5 LPS-specific IBG were protected compared with none of 25 treated with IgG made from the preimmune serum of the same rabbit (P < .001). These results demonstrate that purified J5 LPS-specific IgG protects against the lethal consequences of gram-negative bacteremia.
引用
收藏
页码:622 / 629
页数:8
相关论文
共 40 条
[1]  
AKERSTROM B, 1985, J IMMUNOL, V135, P2589
[3]   ANTIBODIES TO LIPOPOLYSACCHARIDES AFTER IMMUNIZATION OF HUMANS WITH THE ROUGH MUTANT ESCHERICHIA-COLI J5 [J].
BAUMGARTNER, JD ;
HEUMANN, D ;
CALANDRA, T ;
GLAUSER, MP .
JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (04) :769-772
[4]   MONOCLONAL ANTIENDOTOXIN ANTIBODIES FOR THE TREATMENT OF GRAM-NEGATIVE BACTEREMIA AND SEPTIC SHOCK [J].
BAUMGARTNER, JD .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1990, 9 (10) :711-716
[5]  
BAUMGARTNER JD, 1985, LANCET, V2, P59
[6]   PURIFICATION AND CHARACTERIZATION OF H.8 ANTIGEN FROM GROUP-B NEISSERIA-MENINGITIDIS [J].
BHATTACHARJEE, AK ;
MORAN, EE ;
RAY, JS ;
ZOLLINGER, WD .
INFECTION AND IMMUNITY, 1988, 56 (04) :773-778
[7]   ANTICRYPTOCOCCAL TYPE-D ANTIBODIES RAISED IN RABBITS [J].
BHATTACHARJEE, AK ;
BENNETT, JE ;
BUNDLE, DR ;
GLAUDEMANS, CPJ .
MOLECULAR IMMUNOLOGY, 1983, 20 (04) :351-359
[8]   TREATMENT OF GRAM-NEGATIVE SEPTIC SHOCK WITH HUMAN-IGG ANTIBODY TO ESCHERICHIA-COLI J5 - A PROSPECTIVE, DOUBLE-BLIND, RANDOMIZED TRIAL [J].
CALANDRA, T ;
GLAUSER, MP ;
SCHELLEKENS, J ;
VERHOEF, J .
JOURNAL OF INFECTIOUS DISEASES, 1988, 158 (02) :312-319
[9]   ORAL CIPROFLOXACIN AND A MONOCLONAL-ANTIBODY TO LIPOPOLYSACCHARIDE PROTECT LEUKOPENIC RATS FROM LETHAL INFECTION WITH PSEUDOMONAS-AERUGINOSA [J].
COLLINS, HH ;
CROSS, AS ;
DOBEK, A ;
OPAL, SM ;
MCCLAIN, JB ;
SADOFF, JC .
JOURNAL OF INFECTIOUS DISEASES, 1989, 159 (06) :1073-1082
[10]   THE EFFICACY OF COMBINATION IMMUNOTHERAPY IN EXPERIMENTAL PSEUDOMONAS SEPSIS [J].
CROSS, AS ;
OPAL, SM ;
PALARDY, JE ;
BODMER, MW ;
SADOFF, JC .
JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (01) :112-118